Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging.

In this paper we report the synthesis and characterization of organically modified silica (ORMOSIL) nanoparticles, covalently incorporating the fluorophore rhodamine-B, and surface-functionalized with a variety of active groups. The synthesized nanoparticles are of ultralow size (diameter approximately 20 nm), highly monodispersed, stable in aqueous suspension, and retain the optical properties of the incorporated fluorophore. The surface of the nanoparticles can be functionalized with a variety of active groups such as hydroxyl, thiol, amine, and carboxyl. The carboxyl groups on the surface were used to conjugate with various bioactive molecules such as transferrin, as well as monoclonal antibodies such as anti-claudin 4 and anti-mesothelin, for targeted delivery to pancreatic cancer cell lines. In vitro experiments have revealed that the cellular uptake of these bioconjugated (targeted) nanoparticles is significantly higher than that of the nonconjugated ones. The ease of surface functionalization and incorporation of a variety of biotargeting molecules, combined with their observed noncytotoxicity, makes these fluorescent ORMOSIL nanoparticles potential candidates as efficient probes for optical bioimaging, both in vitro and in vivo.

[1]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[2]  Seong Huh,et al.  Organic Functionalization and Morphology Control of Mesoporous Silicas via a Co-Condensation Synthesis Method , 2003 .

[3]  O. Terasaki,et al.  Synthesis of carboxylic group functionalized mesoporous silicas (CFMSs) with various structures , 2007 .

[4]  Chung-Yuan Mou,et al.  The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.

[5]  Scott C. Brown,et al.  Nanoparticles for bioimaging. , 2006, Advances in colloid and interface science.

[6]  S. Davis,et al.  Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. , 1997, Trends in biotechnology.

[7]  C. Lai.  [26] Detection of peptides by fluorescence methods , 1977 .

[8]  C. Batich,et al.  Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells. , 2005, Journal of nanoscience and nanotechnology.

[9]  D. Faigel,et al.  Novel Markers of Pancreatic Adenocarcinoma in Fine-Needle Aspiration: Mesothelin and Prostate Stem Cell Antigen Labeling Increases Accuracy in Cytologically Borderline Cases , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[10]  A. Walcarius,et al.  Rate of Access to the Binding Sites in Organically Modified Silicates. 1. Amorphous Silica Gels Grafted with Amine or Thiol Groups , 2002 .

[11]  S. Batra,et al.  Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. , 2006, American journal of clinical pathology.

[12]  Robert N Grass,et al.  In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. , 2006, Environmental science & technology.

[13]  C. Lai.  Detection of peptides by fluorescence methods. , 1977, Methods in enzymology.

[14]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[15]  Weihong Tan,et al.  Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. , 2003, Journal of the American Chemical Society.

[16]  A. J. Nijdam,et al.  Nanotechnologies for biomolecular detection and medical diagnostics. , 2006, Current opinion in chemical biology.

[17]  Glenn Walter,et al.  Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. , 2005, Chemical communications.

[18]  Christine A Iacobuzio-Donahue,et al.  Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. , 2004, American journal of clinical pathology.

[19]  S. Armes,et al.  Zeta potential measurements on conducting polymer-inorganic oxide nanocomposite particles , 1994 .

[20]  Prabuddha Sengupta,et al.  Core/Shell fluorescent silica nanoparticles for chemical sensing: towards single-particle laboratories. , 2006, Small.

[21]  Earl J. Bergey,et al.  Nanotechnology in BioMedical Applications , 2002 .

[22]  Hooisweng Ow,et al.  Bright and stable core-shell fluorescent silica nanoparticles. , 2005, Nano letters.

[23]  Tymish Y. Ohulchanskyy,et al.  Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Davis,et al.  Nanoparticles in drug delivery. , 1987, Critical reviews in therapeutic drug carrier systems.

[25]  Shraboni Das,et al.  Inorganic-organic hybrid nanoparticles from n-octyl triethoxy silane. , 2002, Journal of colloid and interface science.

[26]  A. P. Alivisatos,et al.  Less is more in medicine. , 2001, Scientific American.

[27]  Raheela Ashfaq,et al.  Claudin 4 Protein Expression in Primary and Metastatic Pancreatic Cancer , 2004 .

[28]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Julia Cordek,et al.  Direct Immobilization of Glutamate Dehydrogenase on Optical Fiber Probes for Ultrasensitive Glutamate Detection , 1999 .

[30]  Dwaine F Emerich,et al.  Nanomedicine – prospective therapeutic and diagnostic applications , 2005, Expert opinion on biological therapy.

[31]  Indrajit Roy,et al.  Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.

[32]  M. Bissell,et al.  A Rapid Bioassay for Single Bacterial Cell Quantitation Using Bioconjugated Nanoparticles , 2006 .

[33]  C. Sanchez,et al.  A general one-pot process leading to highly functionalised ordered mesoporous silica films. , 2004, Chemical communications.

[34]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[35]  E. Stachowiak,et al.  Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Paras N. Prasad,et al.  Introduction to Biophotonics , 2003 .

[37]  Tymish Y. Ohulchanskyy,et al.  Aqueous ferrofluid of magnetite nanoparticles: Fluorescence labeling and magnetophoretic control. , 2005, The journal of physical chemistry. B.

[38]  A. Maitra,et al.  Nanometer Silica Particles Encapsulating Active Compounds: A Novel Ceramic Drug Carrier , 1998 .

[39]  C. E. White,et al.  Fluorescence analysis : a practical approach , 1970 .

[40]  Weihong Tan,et al.  DESIGNING A NOVEL MOLECULAR BEACON FOR SURFACE-IMMOBILIZED DNA HYBRIDIZATION STUDIES , 1999 .

[41]  A. Walcarius,et al.  Rate of Access to the Binding Sites in Organically Modified Silicates. 2. Ordered Mesoporous Silicas Grafted with Amine or Thiol Groups , 2003 .

[42]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[43]  W. Chan,et al.  Optimizing the Synthesis of Red- to Near-IR-Emitting CdS-Capped CdTexSe1-x Alloyed Quantum Dots for Biomedical Imaging , 2006 .

[44]  W. Tan,et al.  Biochemically functionalized silica nanoparticles. , 2001, The Analyst.